FEBRUARY 2018
H
business elite canada 27
collaborations between clinicians and
basic scientists, which keeps the basic
science grounded on clinical needs.
Over the past decades, they have
mounted cutting edge, and some-
times exclusive, experimental capa-
bilities to investigate SCDs.
Indeed, few institutions in the world
have the capacity to fully address
these critical diseases that need to be
tackled by groups combining exper-
tise in obesity, cardiometabolic and
respiratory health, inflammation, the
complex endocannabinoid system,
adipose tissue biology, gut physiol-
ogy and microbiome profiling.
PUBLIC EDUCATION
As complex as the research is, one
thing is commonly understood: SCDs
